This announcement is a separate document:
佐力药业：7-2 会计师事务所回复意见（修订稿）
Zoli Pharmaceutical: 7-2 Accounting Firm Response Comments (Revised Draft)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.